Researchers have observed that glucagon-receptor activation produces a substantial portion of its metabolic effect through hepatic lipid handling and whole-body energy expenditure, rather than through hepatic glucose output alone
Here's What You Need to Know GLP-1 receptor agonists including Wegovy (semaglutide), Ozempic (semaglutide), and Mounjaro (tirzepatide) have transformed the way millions of people manage weight and blood sugar
Head to Pomegranates site and start the intake questionnaire
)
Niya Mansuri, weight loss expert at myBMI Wegovy 0.25 mg, FlexTouch solution for injection in pre-filled pen (2026) EMC [accessed 9 March 2026] Ozempic 0.25 mg solution for injection in pre-filled pen (2025) EMC [accessed 9 March 2026] Non-alcoholic fatty liver disease (NAFLD) (2025) NHS [accessed 9 March 2026] Sleep apnoea (2022) NHS [accessed 9 March 2026] Physical activity guidelines for adults aged 19 to 64 (2024) NHS [accessed 9 March 2026] Semaglutide for managing overweight and obesity (2023) NICE [accessed 9 March 2026] Tirzepatide for managing overweight and obesity (2025) NICE [accessed 9 March 2026] Once-weekly semaglutide 72 mg in adults with obesity (STEP UP): a randomised, controlled, phase 3b trial (2025) National Library of Medicine [accessed 9 March 2026] Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension (2022) National Library of Medicine [accessed 9 March 2026] Wegovy (2025) Novo Nordisk [accessed 9 March 2026] Its natural to have questions, and were here to keep things straightforward so you can stay focused on your journey

Because obviously we want to have this whole landscape change
Most people cant even tell theres liver, as long as you have a good sauce